ES2058201T3 - Esteres de castanoespermina en el tratamiento de infecciones retrovirales. - Google Patents

Esteres de castanoespermina en el tratamiento de infecciones retrovirales.

Info

Publication number
ES2058201T3
ES2058201T3 ES88115778T ES88115778T ES2058201T3 ES 2058201 T3 ES2058201 T3 ES 2058201T3 ES 88115778 T ES88115778 T ES 88115778T ES 88115778 T ES88115778 T ES 88115778T ES 2058201 T3 ES2058201 T3 ES 2058201T3
Authority
ES
Spain
Prior art keywords
treatment
castanespermine
esters
retroviral infections
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88115778T
Other languages
English (en)
Inventor
Paul S Liu
Terry L Bowlin
Sai P Sunkara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2058201T3 publication Critical patent/ES2058201T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PRESENTAN CIERTOS DERIVADOS DE ESTERES DECASTANOSPERIMINA QUE SON EFICACES EN EL TRATAMIENTO DE INFECCIONES RETROVIRALES QUE INCLUYEN LAS INFECCIONES HIV Y SON DE ESTA MANERA UTILES EN EL TRATAMIENTO DEL SIDA.
ES88115778T 1987-09-29 1988-09-26 Esteres de castanoespermina en el tratamiento de infecciones retrovirales. Expired - Lifetime ES2058201T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/102,070 US5004746A (en) 1987-09-29 1987-09-29 Anti-retroviral castanospermine esters

Publications (1)

Publication Number Publication Date
ES2058201T3 true ES2058201T3 (es) 1994-11-01

Family

ID=22287973

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88115778T Expired - Lifetime ES2058201T3 (es) 1987-09-29 1988-09-26 Esteres de castanoespermina en el tratamiento de infecciones retrovirales.

Country Status (12)

Country Link
US (1) US5004746A (es)
EP (1) EP0309952B1 (es)
JP (1) JP2761898B2 (es)
KR (1) KR960009416B1 (es)
AT (1) ATE107506T1 (es)
AU (1) AU614993B2 (es)
DE (1) DE3850335T2 (es)
DK (1) DK172788B1 (es)
ES (1) ES2058201T3 (es)
IE (1) IE64311B1 (es)
PH (1) PH24431A (es)
ZA (1) ZA887160B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003903A1 (en) * 1985-12-23 1987-07-02 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis
US5214050A (en) * 1989-10-17 1993-05-25 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
AU628228B2 (en) * 1989-10-17 1992-09-10 Merrell Dow Pharmaceuticals Inc. Esters of castanospermine in the treatment of cerebral malaria
GB8924292D0 (en) * 1989-10-27 1989-12-13 Novalal Ltd The production of a novel dimer chemical product"novo dimers"by the polymersation of indolizidine alkaloids using cyclo dextrin glucosyl transferase
US5028614A (en) * 1990-03-30 1991-07-02 Merrell Dow Pharmaceuticals Inc. Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors
GB9027433D0 (en) * 1990-12-18 1991-02-06 Merrell Dow Pharma Anti-herpes castanospermine esters
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
GB9303518D0 (en) * 1993-02-22 1993-04-07 Merrell Dow Pharma Combinations of retroviral inhibitors
IT1269862B (it) * 1994-05-30 1997-04-15 Indena Spa Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono
NZ500639A (en) * 1997-05-22 2001-08-31 Aventis Pharma Inc Process for preparing and purifying 6-O-monoesters of castanospermine ([1S-(-alpha, 6-beta, 7-alpha, 8-beta, 8-alphabeta)]-octahydro-1,6,7,8-indolizinetetrol
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
WO2006085141A2 (en) * 2004-08-13 2006-08-17 Migenix Inc. Compositions and methods for treating or preventing hepadnaviridae infection
CA2583351A1 (en) * 2004-10-06 2006-04-13 Migenix Inc. Combination anti-viral compositions comprising castanospermine and methods of use
CN102727437A (zh) * 2006-08-02 2012-10-17 牛津大学院长校长专家委员会 病毒感染的脂质体治疗
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
EP2410989A2 (en) * 2009-03-27 2012-02-01 The Chancellor, Masters and Scholars of the University of Oxford Cholesterol level lowering liposomes
EP4106752A4 (en) 2020-02-21 2024-03-20 Florida State University Research Foundation, Inc. TREATMENT OF HUMAN CORONAVIRUS INFECTIONS USING ALPHA-GLUCOSIDASE-GLYCOPROTEIN PROCESSING INHIBITORS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003903A1 (en) * 1985-12-23 1987-07-02 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US4952585A (en) * 1988-12-15 1990-08-28 Merrell Dow Pharmaceuticals Inc. Castanospermine esters in the inhibition of tumor metastasis

Also Published As

Publication number Publication date
JP2761898B2 (ja) 1998-06-04
DE3850335T2 (de) 1994-10-13
ATE107506T1 (de) 1994-07-15
EP0309952B1 (en) 1994-06-22
KR890004701A (ko) 1989-05-09
IE64311B1 (en) 1995-07-26
IE882933L (en) 1989-03-29
PH24431A (en) 1990-06-25
US5004746A (en) 1991-04-02
AU614993B2 (en) 1991-09-19
DK172788B1 (da) 1999-07-19
ZA887160B (en) 1989-05-30
DE3850335D1 (de) 1994-07-28
JPH01106821A (ja) 1989-04-24
KR960009416B1 (en) 1996-07-19
EP0309952A2 (en) 1989-04-05
DK538888D0 (da) 1988-09-28
AU2280288A (en) 1989-04-06
DK538888A (da) 1989-03-30
EP0309952A3 (en) 1990-09-26

Similar Documents

Publication Publication Date Title
KR960009416B1 (en) Anti-retroviral castanospermine esters
EP0706373A4 (en) TAXOL ENCLOSED IN LIPOSOMES AND METHOD OF USE
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
DK441786A (da) Nucleosider, der kan anvendes terapeutisk
FI981591L (fi) AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita
YU71489A (en) New substituted azetidinones as anti-inflammatoric and antidegenerative agents
ES2033442T3 (es) Procedimiento para preparar una composicion farmaceutica a base de acidos grasos.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
DK177888D0 (da) Terapeutiske nukleosider
DE69112192D1 (de) Antiherpes-Castanosperminester.
FI832353A7 (fi) Psoriasiksen hoidossa käyttökelpoisia polyolefiinisia -alkyylikarboksyylihappoja ja niiden johdannaisia.
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
KR950700896A (ko) 신규의 심장 보호제(Novel Cardioprotective Agents)
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
GR3004272T3 (es)
NO900616L (no) Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale.
FI925209A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva heterocykliskt substituerade foereningar

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 309952

Country of ref document: ES